Connect with us

In Store

Missouri Rolls Out Decals To Identify Licensed Cannabis Dispensaries

Published

on

Missouri Rolls Out Decals To Identify Licensed Cannabis Dispensaries

A new initiative designed to help cannabis patients and consumers identify licensed cannabis dispensaries and products is being implemented by the Missouri Department of Health and Senior Services’ Division of Cannabis Regulation.

The initiative is called “Verified Dispensary: ​​We’re on the List.”

It aims to provide tools to support informed purchasing decisions, including a government sticker attached to an interactive dispensary map and guidance on how to identify regulated products, according to a news release.

“Missouri residents should be able to make informed decisions about where they access cannabis products if they choose to do so,” said department director Amy Moore in a news release. “The sticker shows that the cannabis business is licensed and regulated by the state and that its products meet health and safety regulatory requirements.”

To read the rest of KOMO, Click here

Post Missouri issues stickers to identify licensed cannabis dispensaries first appeared on Marijuana Retail Report – News and information for cannabis retailers.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Best Practices

What Cultivators Are Talking About In New Jersey

Published

on

By

What Cultivators Are Talking About In New Jersey

New Jersey is a highly desirable cannabis market for new operators due to its rapid multi-billion dollar growth, strong consumer demand and status as one of the most profitable yet underserved markets on the East Coast.

Cultivators gathered at the recent IgniteIt event to share their perspective on the market. Genetic conservation, cost reduction, the future of breeding and what makes a great breeder were some of the key topics.

What makes a good cultivator?

In addition to operational cuts, the cultivator must be able to “read the room” in his cultivation room. Panelist Chad Salyut, Head of Cultivation at iAnthus, which has been growing since the 90s, says, “It’s not just the environment, the lighting or the watering strategy.” He added that great growers are the ones who can come in, read the plants and push them as hard as possible to get the most expression.

Salute explained that the best producers rely on constant observation and hands-on adjustments. They monitor subtle signs such as plant color, canopy structure and changes, and then fine-tune conditions daily. He compared the process to the training of athletes, noting that strong vegetative growth lays the foundation for peak performance later in the cycle. Ultimately, he said, the difference comes down to experience and instinct. The best growers can scan thousands of plants, detect small microecological problems, and make targeted changes that produce the highest quality results.

Josh Crane, Fractional Head of Innovation at Justice Cannabis, adds, “If someone doesn’t have those ‘goggles’, the best SOPs, the best building, and the best nutrients won’t get you to the best expression of that plant.” He added: “For each variety, I need a few rotations with the plant to really understand how it has responded to the changes we’ve made and if we’re getting the best out of that plant and if it’s going to stay in our cultivation for a long time.”

To read the rest of this Cannabis Industry Journal article, Click here

Post What New Jersey Growers Are Talking About first appeared on Marijuana Retail Report – News and information for cannabis retailers.

Continue Reading

Illinois

Marijuana Retail Report

Published

on

By

Marijuana Retail Report



Price pressure is contributing to the decline


Adult cannabis retailers in Illinois sold a record amount of the product in 2025, but falling prices led to a $200 million drop in sales revenue from last year.

Recreational cannabis stores 52.1 million units were sold last yearcompared to 49 million in 2024, according to the Illinois Department of Financial and Professional Regulation.

Still, retailers saw just $1.5 billion in revenue — down from a record $1.7 billion in 2024 — amid price cuts affecting markets across the country.

Latest data available April 2025. 21.8 million dollars of medical marijuana was sold compared to $25 million in April 2024, according to the Illinois Medical Cannabis Patient Program.

Annual MMJ sales were not immediately available. Illinois regulators did not immediately respond to MJBizDaily’s request for comment.

The drop in prices is due to lower prices at the tills, even as retailers are busier than ever. Flower prices fell from a high of $17.50 per gram in April 2020 to $5.72 in November, according to the official cannabis regulator.

To read the rest of this article on MJ Biz Daily, Click here

Continue Reading

Best Practices

Marijuana Retail Report

Published

on

By

Marijuana Retail Report



This can happen in the “next few weeks”

Last week President Trump – told reporters What his administration considered the opportunity to transfer marijuana and will be determined within the next few weeks. It was good to hear the update on this issue because everything stopped since Trump took office in January. Of course, the cannabis industry used to work in a suspended state; But losing the momentum is difficult.

I do not predict whether the marijuana will be reorienting on the III schedule, according to HHS’s recommendations And Biden’s plan, whether we get the worst or best result. Instead, I’m going to explain how it should work. There are four basic paths:

  1. restore the process of delaying norms to accept the proposal of the last year by place marijuana in schedule III;
  2. Start a new process of development of norms, presumably with the new proposed rule;
  3. Hearing of the Novokny norms Jettison in general, and Doj simply publishes the final rule by placing marijuana on schedule III (or anywhere); or
  4. Do nothing. Say: “We like marijuana where she is, science and The contracts will be cursed

I will give some high -level thoughts about each of these paths below. However, one thing to apply to the beginning is often a re-fiction that Trump could simply re-re-decide marijuana through the executive order. He can’t. However, he could send the process, like Biden, when Biden issued an executive order 2022, sending HHS to revise marijuana control status. Essentially, Trump could say what he wanted to see, and this would probably happen, especially given the strict loyalty that DOJ showed.

Option 1: Restore Development Development process

Trump could manage Doj and Dea to restore A scary competition redevelopment of marijuana. There are several questions with this. For the first time, the application of the norms was configured from the route, to a large extent with the bad behavior of DEA. Secondly, the judge who oversees the process has retired, and Doj now holds the post that the judges of administrative law are unconstitutional. Third, this process, which is essentially a lawsuit, can pull further and further. If Trump’s administration decides what he wants marijuana somewhere except the schedule and I don’t think they will like it.

Option 2: Start a new process development process

Trump can send Doj to issue a new message proposed by placement of marijuana on III or some other schedule. Doj may claim that the previous process has been improved and/or spoiled, and lost any legitimacy veneer. This justification is likely to resist control, but I’m not sure it can be obtained from another circus involved, especially depending on the recent HHS recommendations. And again, Doj Trump is declining from administrative judges.

Option 3: No more hearings; straight to the final rule

I explained in the previous message that:

CSA “Welsh” General Prosecutor Has Powers “Schedule, Post or Deconerol” (21 USC 811 (A)). The Attorney General traditionally delegated this power to the DEA administrator (28 CFR 0.100). However, the Prosecutor General also retains the powers to plan drugs within CSA in “first instance” (28 USC 509. 510).

(Merick) Garlend had to do so. Instead – noted On the day when HHS made a recommendation to overpay. Garland’s decision is also excited Nest of the Horos of Tired Legal Arguments Around the delegation, whether Dea should be a fan here, etc.

If Trump’s administration decides to move marijuana, Doj must simply write the final rule. The marijuana can then go to the III schedule (either anywhere) within 30 or 60 days of publication. People could consider this rule confident. Considering the power of HHS, however, the clear authorized authority that stands for Doj seems like a heavy battle.

Option 4: Do nothing; marijuana stays on the schedule I

To me, this seems more likely than 1 or 2 options; and less likely than option 3. I say that with low confidence, remember you. I don’t know what’s going on behind the scenes.

If the Trump administration decides to leave marijuana where it is, then the ball returned to Congress. CSA leads to Congress the possibility of re -drug re -executives, of course, in parallel to the executive power. Congressman Greg Steb (R-FL) again filed his “Marijuana law from 1 to 3” Last weekIt will require the Prosecutor General to transfer marijuana to the III schedule within 60 days after passing. This is one potential bill.

If the Doj is not instructed to write the final rule, I would like Trump administration to demand Congress to take this and Congress to do it. As my colleague Jason AdeLston explained recently“Unlike the executive power, Congress can create a solid legal base for marijuana that protects the industry from regulation.”

As said Jake BarnesDon’t it think really?

Source: Blog Law Canna

(Tagstotranslate) Donald Trump (T) Attached (T) Federal (T) redevelopment

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media